Research Article
Characteristics of Gut Microbiota in Female Patients with Diabetic Microvascular Complications
Table 2
Clinical characteristics of the patients.
| | Variable | T2DM-0 group () | T2DM-MC group () | | |
| | Age (years) | 57.20 ± 7.44 | | 2.02 | 0.051 | | BMI (kg/m2) | | | 1.203 | 0.237 | | Family history (%) | 10 (50%) | 7 (41.18%) | 0.288 | 0.591 | | HbA1c (%) | | | 2.091 | 0.044 | | FBG (mmol/L) | | | 1.788 | 0.082 | | 2hPG (mmol/L) | | | 1.007 | 0.321 | | Hypertension (%) | 12 (60.00%) | 11 (64.71%) | 0.087 | 0.769 | | Hyperlipidemia (%) | 13 (65.00%) | 12 (70.59%) | 0.266 | 0.606 | | CRE (μmol/L) | 50.05 (43.00, 57.08) | 60.4 (47.42, 85.69) | -1.417 | 0.156 | | Diabetic macrovascular complications | 1 (5.00%) | 2 (10.00%) | 0.564 | 0.452 | | Medication status of antidiabetic agents | | | | | | Metformin (%) | 18 (90.00%) | 14 (82.35%) | 0.46 | 0.498 | | α-Glycosidase inhibitor (%) | 5 | 4 | 0.011 | 0.917 | | Insulin (%) | 13 (65.00%) | 13 (76.47%) | 0.579 | 0.447 |
|
|
Abbreviations: T2DM-0: no diabetic microvascular complications; T2DM-MC: diabetic microvascular complications; BMI: body mass index; HbA1c: glycated hemoglobin A1c; FBG: fasting blood glucose; 2hPG: 2 h plasma glucose; CRE: serum creatinine. was considered statistically significant. |
